Home
Transactions

Work Area: Transactions

SVB’s collapse is a reminder of how far IP finance still has to travel

Like many others, the bank held thousands of patents as security for loan deals, but almost certainly had no idea of their value – or lack of it

Five patent takeaways from Pfizer’s $43 billion Seagen buyout

The takeover of the biopharma innovator is the largest pharma sector deal since 2019

Global tax revolution will put corporate IP strategies under far greater scrutiny

New rules on transfer pricing drawn up by the OECD, which could be adopted by authorities in well over 100 countries, are set to have a major impact on how businesses manage their intangible assets

Latest content

US patent sales decline continues, but full picture is elusive

Featured in Secondary Market Activity

Data platform changes at the USPTO may mean transactions are being recorded more slowly than usual, says AST

08 December 2022

Merck’s $1.35 billion purchase is the latest deal driven by patent cliff fears

Imago BioSciences buyout is intended to diversify the company’s revenue streams

28 November 2022

Your guide to synthetic drug royalty dealmaking

Selling revenue streams is an increasingly important way of monetising pharma innovations

16 November 2022

Five key patent transactions takeaways

An over-arching theme during an IAM event was the key importance of relationships, trust and empathy between parties when deals are getting done

11 November 2022

WiLAN revenues plummet in Q3 on prior year but Micron deal excluded

Strategic review of the licensing business nears a year in motion with no news on potential divestment announced

10 November 2022

Drug royalty agreements can help Big Pharma overcome patent cliffs, says top dealmaker

Behzad Khosrowshahi, CEO of DRI Healthcare Trust, looks at recent deals the firm has done, explains what makes a transaction attractive and how to get one over the line

04 November 2022

France Brevets’ public sector links hindered monetisation efforts, says CEO

As the sovereign patent fund closes down, CEO Didier Patry shares his thoughts with IAM readers on the organisation’s work over the past decade

03 November 2022

IP finance, monetisation and much more take centre stage on Day One of IPBC Asia 2022

A broad range of subjects and talking points - including a plenary address from JPO Commissioner Koichi Hamano - kept the 400+ delegates engaged as the event got underway in Tokyo

01 November 2022

BlackBerry has ‘lost the signal’ … again

The series of missteps and errors in the Canadian company’s struggling patent portfolio sale offers a cautionary tale to any IP owner emulating this in future

29 October 2022

Myovant $2.9 billion buyout is the product of smart IP deal-making

The company’s high value was produced by a series of innovative patent transactions

27 October 2022

Unlock unlimited access to all IAM content